Price targets for Insulet Corporation (PODD) are dynamic figures determined by financial analysts at major investment firms, reflecting their latest outlook on the company's growth, market share capture, and earnings potential. As of mid-2026, these targets are calculated based on projected revenue from the Omnipod product line, the success of international market expansion, and the anticipated margin improvements driven by greater production scale. Because analysts operate with different methodologies and assumptions regarding competitive pressure in the diabetes-tech market, you will find a wide range of estimates across various brokerage research reports. Investors should check their own brokerage research dashboards or reputable financial news outlets for the most recent consensus price targets, remembering that these projections are not guarantees of future performance but are expert estimates that change frequently in response to updated quarterly financial data and broader market shifts in the medical technology sector.